ATE350382T1 - Imidazopyrimidine und triazolopyrimidine: benzodiazepinrezeptorliganden - Google Patents

Imidazopyrimidine und triazolopyrimidine: benzodiazepinrezeptorliganden

Info

Publication number
ATE350382T1
ATE350382T1 AT04779031T AT04779031T ATE350382T1 AT E350382 T1 ATE350382 T1 AT E350382T1 AT 04779031 T AT04779031 T AT 04779031T AT 04779031 T AT04779031 T AT 04779031T AT E350382 T1 ATE350382 T1 AT E350382T1
Authority
AT
Austria
Prior art keywords
imidazopyrimidines
triazolopyrimidines
receptor ligands
benzodiazepine receptor
benzodiazepine
Prior art date
Application number
AT04779031T
Other languages
German (de)
English (en)
Inventor
Linghong Xie
Bingsong Han
Yuelian Xu
George Maynard
Bertrand L Chenard
Kenneth Shaw
Yang Gao
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Application granted granted Critical
Publication of ATE350382T1 publication Critical patent/ATE350382T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04779031T 2003-07-25 2004-07-23 Imidazopyrimidine und triazolopyrimidine: benzodiazepinrezeptorliganden ATE350382T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49000603P 2003-07-25 2003-07-25
US54308304P 2004-02-09 2004-02-09

Publications (1)

Publication Number Publication Date
ATE350382T1 true ATE350382T1 (de) 2007-01-15

Family

ID=34118813

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04779031T ATE350382T1 (de) 2003-07-25 2004-07-23 Imidazopyrimidine und triazolopyrimidine: benzodiazepinrezeptorliganden

Country Status (20)

Country Link
US (2) US7271170B2 (https=)
EP (1) EP1648899B1 (https=)
JP (1) JP2007500130A (https=)
KR (1) KR20060098425A (https=)
AR (1) AR045117A1 (https=)
AT (1) ATE350382T1 (https=)
AU (1) AU2004261591A1 (https=)
BR (1) BRPI0412908A (https=)
CA (1) CA2537331A1 (https=)
CY (1) CY1107565T1 (https=)
DE (1) DE602004004143T2 (https=)
DK (1) DK1648899T3 (https=)
ES (1) ES2278345T3 (https=)
IL (1) IL173265A0 (https=)
MX (1) MXPA06000887A (https=)
NZ (1) NZ544262A (https=)
PL (1) PL1648899T3 (https=)
PT (1) PT1648899E (https=)
TW (1) TW200524937A (https=)
WO (1) WO2005012306A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7482366B2 (en) * 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
CA2524376A1 (en) * 2003-05-05 2004-12-16 Neurogen Corporation Substituted imidazolopyrazine and triazolopyrazyne derivatives: gabaa receptor ligands
US20080167324A1 (en) * 2005-03-02 2008-07-10 Yuelian Xu Thiazolymethyl and Oxazolylmethyl Heteroaryl Derivatives
US7709468B2 (en) 2005-09-02 2010-05-04 Abbott Laboratories Imidazo based heterocycles
EP2146576A4 (en) * 2007-04-11 2013-01-16 Cypress Bioscience Inc TREATMENT OF DOWN SYNDROME WITH BENZODIAZEPINE REACTANT AGONISTS
US8546394B2 (en) 2007-04-17 2013-10-01 Bristol-Myers Squibb Company Substituted [1,2,4]triazolo[4,3-A]pyrazine 11-beta-hydroxysteroid dehydrogenase inhibitors
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
US20090270373A1 (en) * 2008-04-11 2009-10-29 Cypress Biosciences, Inc. Treatment of down syndrom with benzodiazepine receptor antagonists

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US544057A (en) * 1895-08-06 Bill and letter file
AU4058000A (en) * 1999-04-02 2000-10-23 Neurogen Corporation Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulatorsof gabaa receptors
US6737242B1 (en) * 1999-05-07 2004-05-18 Neurogen Corporation Methods for screening GABA-modulatory compounds for specified pharmacological activities
GB9929687D0 (en) * 1999-12-15 2000-02-09 Merck Sharp & Dohme Therapeutic agents
AU2001270297A1 (en) * 2000-06-30 2002-01-14 Neurogen Corporation 2-phenylimidazo(1,2-a)pyridine derivatives: a new class of gaba brain receptor ligands
GB0027561D0 (en) 2000-11-10 2000-12-27 Merck Sharp & Dohme Therapeutic agents
US6900215B2 (en) * 2000-12-15 2005-05-31 Merck Sharp & Dohme Ltd. Imidazo-pyrimidine derivatives as ligands for gaba receptors
PA8535601A1 (es) 2000-12-21 2002-11-28 Pfizer Derivados benzimidazol y piridilimidazol como ligandos para gabaa
TWI248936B (en) * 2001-03-21 2006-02-11 Merck Sharp & Dohme Imidazo-pyrimidine derivatives as ligands for GABA receptors
ATE338758T1 (de) 2001-03-23 2006-09-15 Merck Sharp & Dohme Imidazopyrimidin-derivate als liganden für gaba- rezeptoren
IL159811A0 (en) * 2001-07-13 2004-06-20 Neurogen Corp Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands
GB0128499D0 (en) * 2001-11-28 2002-01-23 Merck Sharp & Dohme Therapeutic agents
JP2005531548A (ja) * 2002-05-02 2005-10-20 ニューロジェン コーポレイション 置換イミダゾール誘導体：ｇａｂａａ受容体リガンド
JP2006515278A (ja) * 2002-05-08 2006-05-25 ニューロジェン コーポレイション 置換イミダゾリルメチルピリジン及びピラジン誘導体並びにそれらのｇａｂａａ受容体リガンドとしての使用
DE60306918T2 (de) * 2002-05-17 2007-03-01 Neurogen Corp., Branford Substituierte, ringkondensierte imidazolderivate: gabaa-rezeptorliganden
CN100579579C (zh) * 2002-10-01 2010-01-13 诺华疫苗和诊断公司 抗癌及抗感染性疾病组合物及其使用方法
ATE335732T1 (de) 2002-11-08 2006-09-15 Neurogen Corp 4-imidazol-1-ylmethylpyrimidinderivate als liganden für gabaa-rezeptoren
CA2524376A1 (en) 2003-05-05 2004-12-16 Neurogen Corporation Substituted imidazolopyrazine and triazolopyrazyne derivatives: gabaa receptor ligands

Also Published As

Publication number Publication date
NZ544262A (en) 2009-06-26
WO2005012306A2 (en) 2005-02-10
DK1648899T3 (da) 2007-04-02
MXPA06000887A (es) 2006-04-19
KR20060098425A (ko) 2006-09-18
US7271170B2 (en) 2007-09-18
DE602004004143D1 (de) 2007-02-15
JP2007500130A (ja) 2007-01-11
ES2278345T3 (es) 2007-08-01
PT1648899E (pt) 2007-03-30
PL1648899T3 (pl) 2007-06-29
EP1648899A2 (en) 2006-04-26
BRPI0412908A (pt) 2006-09-26
CY1107565T1 (el) 2013-03-13
US20050038043A1 (en) 2005-02-17
WO2005012306A3 (en) 2005-04-14
TW200524937A (en) 2005-08-01
EP1648899B1 (en) 2007-01-03
US20080139580A1 (en) 2008-06-12
IL173265A0 (en) 2006-06-11
AU2004261591A1 (en) 2005-02-10
HK1089446A1 (en) 2006-12-01
DE602004004143T2 (de) 2007-10-11
AR045117A1 (es) 2005-10-19
CA2537331A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
ATE272639T1 (de) Imidazopyrimidin-derivate und triazolopyrimidin- derivate
NO20053955D0 (no) Pyrazolo [1,5-A] pyrimidinderivater
DK1699795T3 (da) Substituerede 8'-pyri(mi)dinyldihydrospiro[cycloalkylamin]-pyrimido[1,2-a]pyrimidin-6-onderivater
EP1734820A4 (en) Imidazopyrrazine, imidazopyridine, and imidazo-pyrimidine as CRF1 receptor ligands
IL180757A0 (en) Imidazo[4,5-d] pyrimidines, their uses and methods of preparation
IL183110A0 (en) Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
DE50302207D1 (de) Alkyl-substituierte pyrazolopyrimidine
GB2404359B (en) Child vehicle seat
IL175915A0 (en) Substituted imidazo ring systems and methods
ZA200606615B (en) Heteroaryl-fused pyrazolo derivatives
DK1622912T3 (da) 2-alkynyl- og 2-alkenyl-pyrazolo-[4,3-E]-1,2,4-triazolo-[1,5-C]-pyrimidinadenosin-A2A-receptorantagonister
NO20054330D0 (no) 8-substituerte-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
IL174512A0 (en) Pyrazolo and imidazo-pyrimidine derivatives
NO20054331D0 (no) Substituerte-8-perfluoralkyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
IL177510A0 (en) Pyrazolopyrimidines
DE50208341D1 (de) Triazolopyrimidine
DE502004011106D1 (de) 6-arylmethyl-substituierte pyrazolopyrimidine
DE60103909D1 (de) 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on- und 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5 1honderivate
IL172098A0 (en) Triazolopyrimidines
ATE350382T1 (de) Imidazopyrimidine und triazolopyrimidine: benzodiazepinrezeptorliganden
DE602004004295T8 (de) 6-[(Substituiertes)]Triazolopyrimidine als Antikrebsmittel
PL372989A1 (en) Triazolopyrimidines
ZA200510276B (en) Triazolopyrimidines
GB2425309B (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers
IL177856A0 (en) 2-pyridinyl[7-(substituted-pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1648899

Country of ref document: EP

REN Ceased due to non-payment of the annual fee